GOODRX, INC.

Lobbying for GOODRX, INC.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $350,000.00 expenses · posted Jul 21, 2025

Lobbying activity 2

Health Issues

-Issues regarding prescription drug pricing. -Issues regarding telehealth.

Consumer Issues/Safety/Products

Monitoring federal legislation and outreach to congressional offices.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.